BACKGROUND: The prevalence of childhood overweight and obesity is increasing at dramatic rates in children and adolescents worldwide. Clinical practice guidelines (CPGs) are "systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances." Their objective is to provide explicit recommendations for clinical practice based on current evidence for best practice in the management of diseases. MATERIALS AND METHODS: The aim of this study was to identify and assess the quality of CPGs for the prevention and treatment of obesity and overweight in childhood. We developed a search to identify CPGs published between January 1998 and August 2007. We considered for inclusion documents that provided recommendations for clinical practice referring to children and adolescents. Three independent appraisers assessed the quality of the1 CPGs using the AGREE (Appraisal of Guidelines Research and Evaluation) instrument. We identified 376 references and selected 22 for further assessment. RESULTS: The overall agreement among reviewers using the intraclass correlation coefficient was 0.856 (95% confidence interval [CI] 0.731-0.932). Six of the 22 initial guidelines were recommended and a further eight were recommended with conditions or provisos. We concluded that the number of documents with recommendations on the prevention and treatment of childhood obesity published during the 10-year study period was considerable, but only a few of them could be considered as high quality. CPGs were deficient in areas such as applicability, editorial independence and rigor in development. CONCLUSION: Due to the increasing burden of obesity among children and the potential for long-term comorbidities, clinicians need to be critical in assessing the rigor of how these are developed and their appropriateness for use in the clinician's own practice. There is a need to improve the methodology and the quality of CPGs on childhood obesity to help clinicians and other decision-makers to tackle this disease.
BACKGROUND: The prevalence of childhood overweight and obesity is increasing at dramatic rates in children and adolescents worldwide. Clinical practice guidelines (CPGs) are "systematically developed statements to assist practitioner and patient decisions about appropriate health care for specific clinical circumstances." Their objective is to provide explicit recommendations for clinical practice based on current evidence for best practice in the management of diseases. MATERIALS AND METHODS: The aim of this study was to identify and assess the quality of CPGs for the prevention and treatment of obesity and overweight in childhood. We developed a search to identify CPGs published between January 1998 and August 2007. We considered for inclusion documents that provided recommendations for clinical practice referring to children and adolescents. Three independent appraisers assessed the quality of the1 CPGs using the AGREE (Appraisal of Guidelines Research and Evaluation) instrument. We identified 376 references and selected 22 for further assessment. RESULTS: The overall agreement among reviewers using the intraclass correlation coefficient was 0.856 (95% confidence interval [CI] 0.731-0.932). Six of the 22 initial guidelines were recommended and a further eight were recommended with conditions or provisos. We concluded that the number of documents with recommendations on the prevention and treatment of childhood obesity published during the 10-year study period was considerable, but only a few of them could be considered as high quality. CPGs were deficient in areas such as applicability, editorial independence and rigor in development. CONCLUSION: Due to the increasing burden of obesity among children and the potential for long-term comorbidities, clinicians need to be critical in assessing the rigor of how these are developed and their appropriateness for use in the clinician's own practice. There is a need to improve the methodology and the quality of CPGs on childhood obesity to help clinicians and other decision-makers to tackle this disease.
Authors: I D Graham; S Beardall; A O Carter; J Glennie; P C Hébert; J M Tetroe; F A McAlister; S Visentin; G M Anderson Journal: CMAJ Date: 2001-07-24 Impact factor: 8.262
Authors: Linda H Harpole; Michael J Kelley; Gilbert Schreiber; Eric M Toloza; Jane Kolimaga; Douglas C McCrory Journal: Chest Date: 2003-01 Impact factor: 9.410
Authors: Phyllis W Speiser; Mary C J Rudolf; Henry Anhalt; Cecilia Camacho-Hubner; Francesco Chiarelli; Alon Eliakim; Michael Freemark; Annette Gruters; Eli Hershkovitz; Lorenzo Iughetti; Heiko Krude; Yael Latzer; Robert H Lustig; Ora Hirsch Pescovitz; Orit Pinhas-Hamiel; Alan D Rogol; Shlomit Shalitin; Charles Sultan; Daniel Stein; Pnina Vardi; George A Werther; Zvi Zadik; Nehama Zuckerman-Levin; Zeev Hochberg Journal: J Clin Endocrinol Metab Date: 2004-12-14 Impact factor: 5.958
Authors: Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal Journal: JAMA Date: 2006-04-05 Impact factor: 56.272
Authors: Karen J Coleman; Anne C Hsii; Corinna Koebnick; Ana F Alpern; Brenna Bley; Marianne Yousef; Erin M Shih; Keila J Trimble-Cox; Ning Smith; Amy H Porter; Steven D Woods Journal: J Pediatr Date: 2012-01-10 Impact factor: 4.406
Authors: You Kyoung Lee; Ein Soon Shin; Jae-Yong Shim; Kyung Joon Min; Jun-Mo Kim; Sun Hee Lee Journal: J Korean Med Sci Date: 2013-01-29 Impact factor: 2.153
Authors: Judith Wylie-Rosett; Adriana E Groisman-Perelstein; Pamela M Diamantis; Camille C Jimenez; Viswanathan Shankar; Beth A Conlon; Yasmin Mossavar-Rahmani; Carmen R Isasi; Sarah N Martin; Mindy Ginsberg; Nirupa R Matthan; Alice H Lichtenstein Journal: Int J Behav Nutr Phys Act Date: 2018-01-22 Impact factor: 6.457